Trials / Conditions / Dilated Cardiomyopathy (DCM)

Dilated Cardiomyopathy (DCM)

20 registered clinical trials studyying Dilated Cardiomyopathy (DCM) — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 D NCT07137338	Rocket Pharmaceuticals Inc.	Phase 1
Not Yet Recruiting	BAG3-DCM Natural History Study NCT07486752	Rocket Pharmaceuticals Inc.	—
Not Yet Recruiting	Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy NCT07516288	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 1
Not Yet Recruiting	An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM) NCT07426419	Affinia Therapeutics	Phase 1 / Phase 2
Not Yet Recruiting	Mainstreaming Genetic Testing for Non-Ischemic Cardiomyopathy in Western Canada NCT07345338	Thomas Roston	N/A
Recruiting	Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy NCT07293338	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Not Yet Recruiting	Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF NCT07347197	Heartseed Inc.	Phase 1 / Phase 2
Recruiting	Study of the Progression of Chronic Cardiovascular Conditions NCT07420907	Prolaio	—
Recruiting	Multimodal Analysis of Endomyocardial Biopsies NCT07359690	University Hospital, Essen	—
Recruiting	Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM) NCT06922851	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	N/A
Completed	Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy NCT06902896	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 1
Not Yet Recruiting	Early Identification and Treatment of Rare Cardiomyopathy Cohorts NCT06794710	RenJi Hospital	N/A
Not Yet Recruiting	AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA NCT06748261	Shanghai Zhongshan Hospital	—
Recruiting	Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Ca NCT06741995	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	—
Recruiting	UIC Multi-Ethnic DCM Registry NCT07145138	University of Illinois at Chicago	—
Recruiting	The Application of T1 Mapping in Real-World NCT07354646	Chinese Academy of Medical Sciences, Fuwai Hospital	—
Recruiting	Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Pa NCT06607471	Scientific Institute San Raffaele	—
Unknown	Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) NCT02293603	Capricor Inc.	Phase 1
Enrolling By Invitation	Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias NCT02413450	Johns Hopkins University	—
Unknown	The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study NCT00523653	McGill University Health Centre/Research Institute of the McGill University Health Centre	—